Consolidated Statement of Changes in Equity - USD ($) |
Share capital |
Other equity |
Other reserves |
Accumulated losses |
Non-controlling interests |
Total |
|---|---|---|---|---|---|---|
| Balance at Jun. 30, 2023 | $ 97,230,329 | $ 2,146,566 | $ 10,361,457 | $ (65,353,864) | $ 1,194,937 | $ 45,579,425 |
| Loss for the year | (45,984,906) | (1,964,213) | (47,949,119) | |||
| Other comprehensive income | 202,956 | 202,956 | ||||
| Total comprehensive income/(loss) for the year | 202,956 | (45,984,906) | (1,964,213) | (47,746,163) | ||
| Transactions with owners in their capacity as owners: | ||||||
| Contributions of equity | 3,560,298 | 3,560,298 | ||||
| Transaction costs | (2,633,140) | (2,633,140) | ||||
| Issue of options | 3,372,264 | 3,372,264 | ||||
| Equity-settled payments | 223,526 | (191,834) | 31,692 | |||
| Issue of shares as part of license acquisition | 1,297,022 | (1,297,022) | ||||
| Issue of shares per the share purchase agreement | 900,000 | 900,000 | ||||
| Issue of shares in lieu of services | 103,681 | 103,681 | ||||
| Shares to be issued | 24,185,229 | 24,185,229 | ||||
| Changes in equity | 3,451,387 | (1,297,022) | 27,365,659 | 29,520,024 | ||
| Balance at Jun. 30, 2024 | 100,681,716 | 849,544 | 37,930,072 | (111,338,770) | (769,276) | 27,353,286 |
| Loss for the year | (36,703,089) | (1,639,368) | (38,342,457) | |||
| Other comprehensive income | 464,034 | 464,034 | ||||
| Total comprehensive income/(loss) for the year | 464,034 | (36,703,089) | (1,639,368) | (37,878,423) | ||
| Transactions with owners in their capacity as owners: | ||||||
| Contributions of equity net of transaction costs | 74,915,537 | (23,885,229) | 51,030,308 | |||
| Issue of options | 2,157,778 | 2,157,778 | ||||
| Issue of shares for milestone completion | 741,400 | 741,400 | ||||
| Equity-settled payments | 219,840 | (231,115) | (11,275) | |||
| Expiration of options | (2,797,451) | 2,797,451 | ||||
| Forfeiture of options | (221,170) | (221,170) | ||||
| Cancellation of shares to be issued | (300,000) | (300,000) | ||||
| Increase in ownership in RAD Ventures | (488,544) | 488,544 | ||||
| Changes in equity | 75,876,777 | (25,277,187) | 2,308,907 | 488,544 | 53,397,041 | |
| Balance at Jun. 30, 2025 | 176,558,493 | 849,544 | 13,116,919 | (145,732,952) | (1,920,100) | 42,871,904 |
| Loss for the year | (55,149,150) | (1,801,344) | (56,950,494) | |||
| Other comprehensive income | 621,440 | 621,440 | ||||
| Total comprehensive income/(loss) for the year | 621,440 | (55,149,150) | (1,801,344) | (56,329,054) | ||
| Transactions with owners in their capacity as owners: | ||||||
| Contributions of equity net of transaction costs | 33,374,878 | 33,374,878 | ||||
| Issue of options | 2,740,119 | 2,740,119 | ||||
| Issue of shares for milestone completion | ||||||
| Expiration of options | (1,730,159) | 1,730,159 | ||||
| Forfeiture of options | (334,164) | (334,164) | ||||
| Increase in ownership in RAD Ventures | (1,357,918) | 1,357,918 | ||||
| Impairment – Pharma 15 | (849,544) | 849,544 | ||||
| Changes in equity | 33,374,878 | (849,544) | 675,796 | 1,221,785 | 1,357,918 | 35,780,833 |
| Balance at Jun. 30, 2026 | $ 209,933,371 | $ 14,414,155 | $ (199,660,317) | $ (2,363,526) | $ 22,323,683 |